{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:01:21Z","timestamp":1785448881806,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.acra.2018.05.020","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T02:38:06Z","timestamp":1529548686000},"page":"450-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["68Ga-PSMA PET\/CT in Patients with Rising Prostatic-Specific Antigen After Definitive Treatment of Prostate Cancer: Detection Efficacy and Diagnostic accuracy"],"prefix":"10.1016","volume":"26","author":[{"given":"Maged Abdel Galil","family":"Hamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9075-8020","authenticated-orcid":false,"given":"Mohammad Abd Alkhalik","family":"Basha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussien","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ali","family":"Obaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira Hamed Mohamed","family":"Afifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman H.","family":"Abdelbary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2018.05.020_bib0001","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acra.2018.05.020_bib0002","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent\u2014Update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.acra.2018.05.020_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA-Cancer J Clin"},{"key":"10.1016\/j.acra.2018.05.020_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2478\/v10019-010-0050-8","article-title":"Role of 18F-choline PET\/CT in evaluation of patients with prostate carcinoma","volume":"45","author":"Hodolic","year":"2011","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.acra.2018.05.020_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2478\/v10019-009-0038-4","article-title":"Radiotherapy in palliative treatment of painful bone metastases","volume":"43","author":"Horvat","year":"2009","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.acra.2018.05.020_bib0006","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1148\/radiology.190.2.8284375","article-title":"Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients","volume":"190","author":"Oyen","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2018.05.020_bib0007","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MOU.0b013e3282f13ac3","article-title":"The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery","volume":"18","author":"Pucar","year":"2008","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.acra.2018.05.020_bib0008","doi-asserted-by":"crossref","first-page":"921674","DOI":"10.1155\/2012\/921674","article-title":"Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy","volume":"2012","author":"Kosuri","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.acra.2018.05.020_bib0009","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"H\u00f6vels","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1016\/j.acra.2018.05.020_bib0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0090-4295(96)00161-6","article-title":"Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy","volume":"48","author":"Flanigan","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.acra.2018.05.020_bib0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.juro.2016.07.073","article-title":"Contemporary mapping of post-prostatectomy prostate cancer relapse with 11C-choline positron emission tomography and multiparametric magnetic resonance imaging","volume":"197","author":"Sobol","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.acra.2018.05.020_bib0012","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2016.08.055","article-title":"Identification of site-specific recurrence following primary radiation therapy for prostate cancer using C-11 choline positron emission tomography\/computed tomography: a nomogram for predicting extrapelvic disease","volume":"71","author":"Parker","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.acra.2018.05.020_bib0013","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ijrobp.2016.11.014","article-title":"Patterns of recurrence after postprostatectomy fossa radiation therapy identified by c-11 choline positron emission tomography\/computed tomography","volume":"97","author":"Parker","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2018.05.020_bib0014","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2016.01.029","article-title":"New clinical indications for (18) F\/(11)C-choline, new tracers for positron emission tomography and a promising hybrid device for prostate cancer staging: a systematic review of the literature","volume":"70","author":"Evangelista","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.acra.2018.05.020_bib0015","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","article-title":"Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis","volume":"70","author":"Perera","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.acra.2018.05.020_bib0016","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.eururo.2014.09.004","article-title":"Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature","volume":"67","author":"Ost","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.acra.2018.05.020_bib0017","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1186\/s12885-015-1579-0","article-title":"OLIGOPELVIS - GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer","volume":"15","author":"Supiot","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.acra.2018.05.020_bib0018","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/bju.12279","article-title":"Application of C-11-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature","volume":"112","author":"Mohsen","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.acra.2018.05.020_bib0019","doi-asserted-by":"crossref","unstructured":"Castellucci P, Ceci F, Graziani T, et al. Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET\/CT scan before salvage radiation therapy? J Nucl Med 2014; 55:1424\u20131429.","DOI":"10.2967\/jnumed.114.138313"},{"key":"10.1016\/j.acra.2018.05.020_bib0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2967\/jnumed.114.141887","article-title":"Gleason score at diagnosis predicts the rate of detection of 18F-choline PET\/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients","volume":"56","author":"Cimitan","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2018.05.020_bib0021","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2017.07.011","article-title":"Prostate cancer-specific PET radiotracers: a review on the clinical utility in recurrent disease","volume":"8","author":"Evans","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.acra.2018.05.020_bib0022","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jcb.10661","article-title":"Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer","volume":"91","author":"Ghosh","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.acra.2018.05.020_bib0023","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.acra.2018.05.020_bib0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2214\/AJR.11.7634","article-title":"The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis","volume":"199","author":"Wu","year":"2012","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.acra.2018.05.020_bib0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","article-title":"Evaluation of hybrid 68Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy","volume":"56","author":"Eiber","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2018.05.020_bib0026","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","article-title":"Diagnostic efficacy of (68) Gallium-PSMA-PET compared to conventional imaging in lymph node staging of 130 consecutive patients with intermediate to high-risk prostate cancer","volume":"195","author":"Maurer","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.acra.2018.05.020_bib0027","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2967\/jnumed.116.173492","article-title":"Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy","volume":"57","author":"Rauscher","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2018.05.020_bib0028","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","article-title":"The diagnostic value of PET\/CT imaging with the (68) Ga labelled PSMA ligand HBED CC in the diagnosis of recurrent prostate cancer","volume":"42","author":"Afshar Oromieh","year":"2015","journal-title":"Eur J Nucl Med Mol I"},{"key":"10.1016\/j.acra.2018.05.020_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/diagnostics8010016","article-title":"Review of Gallium-68 PSMA PET\/CT imaging in the management of prostate cancer","volume":"8","author":"Lenzo","year":"2018","journal-title":"Diagnostics"},{"key":"10.1016\/j.acra.2018.05.020_bib0030","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00259-016-3366-9","article-title":"Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with 68Ga-PSMA-HBED-CC than with 18F-fluoroethylcholine PET\/CT","volume":"43","author":"Pfister","year":"2016","journal-title":"Eur J Nucl Med Mol I"},{"key":"10.1016\/j.acra.2018.05.020_bib0031","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/pros.23091","article-title":"Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga PSMA positron emission tomography\/computerized tomography","volume":"75","author":"Hijazi","year":"2015","journal-title":"The Prostate"},{"key":"10.1016\/j.acra.2018.05.020_bib0032","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/RLU.0000000000001197","article-title":"68Ga-PSMA-PET\/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET\/CT","volume":"41","author":"Bluemel","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.acra.2018.05.020_bib0033","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2967\/jnumed.116.184457","article-title":"Detection efficacy of hybrid 68Ga-PSMA ligand PET\/CT in prostate cancer patients with biochemical recurrence after primary radiation therapy defined by Phoenix criteria","volume":"58","author":"Einspieler","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2018.05.020_bib0034","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00259-017-3858-2","article-title":"68 Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy\u2013diagnostic performance and impact on therapeutic decision-making","volume":"45","author":"Grubm\u00fcller","year":"2018","journal-title":"Eur J Nucl Med Mol I"},{"key":"10.1016\/j.acra.2018.05.020_bib0035","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00259-017-3711-7","article-title":"Diagnostic performance of 68 Ga-PSMA-11 (HBED-CC) PET\/CT in patients with recurrent prostate cancer: evaluation in 1007 patients","volume":"44","author":"Afshar-Oromieh","year":"2017","journal-title":"Eur J Nucl Med Mol I"},{"key":"10.1016\/j.acra.2018.05.020_bib0036","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","article-title":"Sensitivity, specificity, and predictors of positive 68Ga\u2013prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis","volume":"70","author":"Perera","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.acra.2018.05.020_bib0037","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1464-410X.2011.10422.x","article-title":"The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up","volume":"109","author":"Antonarakis","year":"2012","journal-title":"BJU Int"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633218302629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633218302629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:45:43Z","timestamp":1761036343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633218302629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1076633218302629"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2018.05.020","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"68Ga-PSMA PET\/CT in Patients with Rising Prostatic-Specific Antigen After Definitive Treatment of Prostate Cancer: Detection Efficacy and Diagnostic accuracy","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2018.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}